LOW-DOSE METHOTREXATE AND SEVERE NEUTROPENIA IN PATIENTS UNDERGOING RENAL DIALYSIS

被引:28
作者
ELLMAN, MH [1 ]
HOU, S [1 ]
GINSBERG, D [1 ]
机构
[1] HIGHLAND PK HOSP,HIGHLAND PK,IL
来源
ARTHRITIS AND RHEUMATISM | 1990年 / 33卷 / 07期
关键词
D O I
10.1002/art.1780330724
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1060 / 1061
页数:2
相关论文
共 5 条
[1]   EFFECT OF ORAL CHOLESTYRAMINE ON THE ELIMINATION OF HIGH-DOSE METHOTREXATE [J].
ERTTMANN, R ;
LANDBECK, G .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1985, 110 (01) :48-50
[2]   PHARMACOKINETICS OF METHOTREXATE IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS [J].
JANKNEGT, R ;
NUBE, MJ ;
VANDENHOOGENBAND, HM ;
OLDENHOF, HGJ ;
STEENHOEK, A ;
VREE, TB .
PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1988, 10 (02) :86-89
[3]  
NURNBERG B, 1988, Arthritis and Rheumatism, V31, pS116
[4]  
STEINBERG SE, 1982, CANCER RES, V42, P1279
[5]   ACUTE RENAL-FAILURE AFTER HIGH-DOSE METHOTREXATE THERAPY - ROLE OF HEMODIALYSIS AND PLASMA-EXCHANGE IN METHOTREXATE REMOVAL [J].
THIERRY, FX ;
VERNIER, I ;
DUEYMES, JM ;
ROCHE, H ;
CANAL, P ;
MEEUS, F ;
POURRAT, JP ;
CONTE, JJ .
NEPHRON, 1989, 51 (03) :416-417